Showing results (321-330 of 436) with videos related to

Sort By:
Pageof 44
Journal of Neurology, Neurosurgery, and Psychiatry|March 8, 2014
Application of whole exome sequencing in undiagnosed inherited polyneuropathiesChristopher J Klein, Sumit Middha, Xiaohui Duan, et al.
Journal of the Peripheral Nervous System : JPNS|November 3, 2010
Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapyMichelle L Mauermann, Bernd W Scheithauer, Robert J Spinner, et al.
Clinical Chemistry|June 26, 2004
Identification of transthyretin variants by sequential proteomic and genomic analysisH Robert Bergen, Steven R Zeldenrust, Malinda L Butz, et al.
Circulation Research|April 24, 2004
Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidationJason R B Dyck, Jie-Fei Cheng, William C Stanley, et al.
Molecular and Cellular Biology|December 14, 2011
Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunctionPetra C Kienesberger, Thomas Pulinilkunnil, Miranda M Y Sung, et al.
Cardiovascular Research|March 23, 2018
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changesNobutoshi Matsumura, Beshay N Zordoky, Ian M Robertson, et al.
Journal of Molecular and Cellular Cardiology|December 4, 2012
Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathwayBenjamin Lauzier, Fanny Vaillant, Clemence Merlen, et al.
Cardiovascular Research|May 28, 2013
Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablationPetra C Kienesberger, Thomas Pulinilkunnil, Jeevan Nagendran, et al.
Atherosclerosis|May 4, 2012
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanismDanna M Breen, Vernon W Dolinsky, Hangjun Zhang, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agentsJie-Fei Cheng, Yujin Huang, Richard Penuliar, et al.
Pageof 44